Early response measurement in non small cell lung cancer.

Early response measurement in non small cell lung cancer. - early response measurement

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON31456

Enrollment

Registered

2008-08-07

Start date

2008-03-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer non-small cell lung cancer

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: stage III with cytologically or histologically proven N2 or N3 disease or T4 patients who are to be treated with concomitant chemoradiotherapy age 18-70 performance status ECOG 0-1 no contraindications for chemo-radiotherapy, surgery or diagnostic procedures

Exclusion criteria

Exclusion criteria: pregnancy previous radiotherapy to the chest

Design outcomes

Primary

Measure	Time frame
Early response assesment during treatment with concomitant chemo-radiotherapy for stage III lung cancer with FDG-PET-CT imaging and biological tumor characteristics.	—

Secondary

Measure	Time frame
Survival, progression-free survival, toxicity.	—

Countries

Netherlands

Outcome results